|
|
Article: Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China.
- Article from:
- Angiogenesis Weekly
- Article date:
- November 6, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioTime, Inc. (OTCBB:BTIM) announced that Dr. David Jin, Chief Medical Officer of BioTime's subsidiary OncoCyte Corporation, will present the keynote address at the Fifth Chinese Congress on Stem Cell Therapy in Beijing, Peoples Republic of China (see also BioTime, Inc.).
The presentation titled, "Chemokine regulation of hematopoietic stem cell mobilization and angiogenesis" will be delivered on Friday, October 23, 2009 on behalf of OncoCyte Corporation and BioTime Asia. The presentation will address the novel therapeutic strategy of using hemangiogenic stem cell technology to target and destroy tumors. This Congress is one of the largest of its type in China ...